类风湿关节炎关节外表现发病率下降:一项基于人群的队列研究
该研究纳入1985至1999年和2000至2014年两个队列共907例符合1987年美国风湿病学会标准的成人类风湿关节炎患者,评估关节外表现累积发病率变化及死亡风险。结果显示任何关节外表现10年累积发病率从45.1%降至31.6%(P<0.001),但有关节外表现者死亡风险仍增高。
要点
- 任何关节外表现10年累积发病率从45.1%降至31.6%(P<0.001)。
- 类风湿因子阳性和当前吸烟是关节外表现的危险因素。
- 非严重和严重关节外表现患者的死亡风险均增高。
核心结论
- 关节外表现发病率随时间下降,但有关节外表现的患者死亡风险仍增高。
研究设计与样本
- 基于人群的起始队列研究,纳入1985至2014年所有符合1987年美国风湿病学会标准的成人类风湿关节炎患者,按发病日期分为1985至1999年队列和2000至2014年队列。
主要发现
- 共纳入907例患者,1985至1999年队列296例,2000至2014年队列611例。
- 任何关节外表现10年累积发病率从1985至1999年队列的45.1%降至2000至2014年队列的31.6%(P<0.001)。
- 皮下类风湿结节10年累积发病率从30.9%降至15.8%(P<0.001),非严重关节外表现从41.4%降至28.8%(P=0.001)。
- 类风湿因子阳性(HR 2.02,95%CI 1.43-2.86)和当前吸烟(HR 1.61,95%CI 1.10-2.34)与任何关节外表现发生相关。
- 非严重关节外表现患者死亡风险增高(HR 1.83,95%CI 1.18-2.85),严重关节外表现患者死亡风险亦增高(HR 3.05,95%CI 1.44-6.49)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The focus of this study was to assess changes in the cumulative incidence of extra-articular manifestations of rheumatoid arthritis (ExRAs) and associated mortality risk. METHODS: This study evaluated trends in occurrence of ExRAs using a population-based inception cohort that included all adult patients with incident rheumatoid arthritis (RA) from 1985 through 2014 meeting the 1987 American College of Rheumatology criteria. Patients were divided into two cohorts based on the incidence date of RA, 1985 to 1999 and 2000 to 2014. The occurrence of ExRAs was determined by manual chart review, and the 10-year cumulative incidence was estimated for each ExRA in both cohorts. Cox proportional hazard models were used to determine associations between specific demographic and RA disease characteristics and ExRAs and between ExRAs and mortality. RESULTS: There were 907 patients included, 296 in the 1985 to 1999 cohort and 611 in the 2000 to 2014 cohort. The 10-year cumulative incidence of any ExRA decreased significantly between the earlier and later cohorts (45.1% vs 31.6%, P < 0.001). This was largely driven by significant declines in subcutaneous rheumatoid nodules (30.9% vs 15.8%, P < 0.001) and nonsevere ExRAs (41.4% vs 28.8%, P = 0.001). Identified risk factors for the development of any ExRAs include rheumatoid factor positivity (hazard ratio [HR] 2.02, 95% confidence interval [CI] 1.43-2.86) and current smoking (HR 1.61, 95% CI 1.10-2.34). Mortality was increased in patients with either nonsevere (HR 1.83, 95% CI 1.18-2.85) or severe ExRAs (HR 3.05, 95% CI 1.44-6.49). CONCLUSIONS: The incidence of ExRAs has decreased over time. Mortality remains increased in patients with ExRAs.
引用
- Kimbrough BA, Crowson CS, Davis JM, et al. Decline in Incidence of Extra-Articular Manifestations of Rheumatoid Arthritis: A Population-Based Cohort Study. Arthritis Care Res (Hoboken). 2023. PMID: 37691141. doi:10.1002/acr.25231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。